Pregnancy in patients with implantable cardiac defibrillators.

Autor: Wong GR; Department of Electrophysiology, St Bartholomews Hospital NHS Trust & Institute of Cardiovascular Science UCL, London, UK., Ang M; Department of Obstetric Imaging, Mercy Hospital for Women, Melbourne, Australia., Jayarajan J; Department of Obstetric Imaging, Mercy Hospital for Women, Melbourne, Australia., Walker F; Department of Grown-Up Congenital Heart Disease, St Bartholomews Hospital, London, UK., Lambiase PD; Department of Electrophysiology, St Bartholomews Hospital NHS Trust & Institute of Cardiovascular Science UCL, London, UK. pier.lambiase@nhs.net.
Jazyk: angličtina
Zdroj: Herzschrittmachertherapie & Elektrophysiologie [Herzschrittmacherther Elektrophysiol] 2021 Jun; Vol. 32 (2), pp. 214-220. Date of Electronic Publication: 2021 May 10.
DOI: 10.1007/s00399-021-00750-x
Abstrakt: The number of patients of reproductive age with inherited and congenital heart disease receiving implantable cardiac defibrillators (ICD) is steadily increasing. Safely and effectively coordinating pregnancy in this high-risk cohort is important to optimise maternal-foetal outcomes. As members of the multidisciplinary team caring for pregnant patients with indications for ICD, cardiologists and electrophysiologists should be aware of the considerations and nuances involved in managing these patients. This article reviews the pathophysiology of arrhythmias, ICD implantation considerations, novel minimal fluoroscopy techniques and subcutaneous ICD. In addition, antenatal and device management during pregnancy and delivery are discussed.
Databáze: MEDLINE
Externí odkaz: